1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Mean metabolite levels within abnormal perfusion and T2h regions compared with contralateral NAWM for grade IV gliomas
Region Choline Creatine Lactate No. Voxels aPH 17.6 ± 10.2 9.1 ± 5.6 4.3 ± 2.3 54 ± 43 aRec 15.9 ± 7.7 8.2 ± 4.7 4.3 ± 2.7 50 ± 70 aPH+aRec 16.1 ± 8.6 8.1 ± 4.9 4.8 ± 3.3 24 ± 38 T2h 14.4 ± 6.4 9.0 ± 4.7 3.4 ± 2.5 172 ± 117 NAWM 16.4 ± 4.5 14.5 ± 3.6 1.2 ± 1.9 N/A
Note:—aPH indicates the region of abnormal peak height with normal recovery; aRec, the region of abnormal recovery with normal peak height; NAWM, normal-appearing white matter; N/A, not applicable.